Robert E. Bristow, MD
Professor and Division Director
University of California, Irvine
101 The City Dr. S
Bldg 56, Rm 800
Irvine,
CA
USA
92868
Biographical Sketch: Dr. Bristow holds the Philip J. DiSaia Prestigious Chair and is Professor and Director of Gynecologic Oncology at the University of California, Irvine School of Medicine and Medical Center. Dr. Bristow’s clinical and research interests include cytoreductive surgery for advanced-stage and recurrent ovarian cancer, health care outcomes, and patterns of gynecologic cancer care. He is an academic gynecologic oncologist and has been extensively published in the peer-reviewed literature on the topic of ovarian cancer outcomes. He has previously presented plenary sessions at the SGO Annual Meeting including the Hugh Barber Lecture."
Papers:
1 - Scientific Plenary
Spatial analysis of geographic location and adherence to treatment guidelines for advanced-stage ovarian cancer: impact of race and socioeconomic status
67 - Featured Poster
Short-term morbidity and mortality associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent/advanced-stage ovarian cancer
89 - Featured Poster
Characteristics of high-volume gynecologic cancer centers – framework toward centers of excellence: a National Cancer Data Base (NCDB) study
92 - Featured Poster
Human papillomavirus vaccination within a Southern California integrated healthcare system demonstrates disparities in adherence rates among males and females compared to national reports
107 - Scientific Plenary
Hospital readmission (30-day) following surgery for advanced-stage ovarian cancer: analysis of risk factors and cost using the SEER-Medicare database
177 - Poster Session A
Evaluating an adnexal mass using a multivariate index assay and imaging
186 - Poster Session A
Gynecologic oncology fellow perspectives on research and career development symposia: a Gynecologic Oncology Fellows' and Allied Health Professionals' Research Network (GOFRN) survey study
227 - Poster Session A
Hyperthermic intraperitoneal chemotherapy in the treatment of ovarian, fallopian tube, and peritoneal cancer: an analysis of recurrence patterns and survival
345 - Poster Session B
Socioeconomic status and health insurance as predictors of access to high-volume hospital care for women with early-stage ovarian cancer
383 - Poster Session B
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer
392 - Poster Session B
Impact of race, socioeconomic status, and the healthcare system on the treatment of advanced-stage ovarian cancer in California
420 - Poster Session B
Geographic disparities in cancer care: is optimizing the distribution of the gynecologic oncology workforce the answer? A Gynecologic Oncology Fellows Research Network study